Virtus Biotech ETF
BBP
9 hedge funds and large institutions have $2.04M invested in Virtus Biotech ETF in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
99% more capital invested
Capital invested by funds: $1.02M → $2.04M (+$1.01M)
29% more funds holding
Funds holding: 7 → 9 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$360K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$298K |
| 3 |
LPL Financial
San Diego,
California
|
+$163K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$16.4K |
| 5 |
CFA
Carroll Financial Associates
Charlotte,
North Carolina
|
+$8.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
-$6K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$5.49K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$690 |
BBP Hedge Fund Activity: Q2 2015 in Review
9 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q2 2015, worth a combined $2.04M — up 99% from $1.02M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BBP positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $360K. The largest seller was Creative Planning, exiting entirely with an estimated $6K sold.
- 9 institutional investors held Virtus Biotech ETF (BBP) as of Q2 2015, up from 7 in Q1 2015.
- Funds reported $2.04M of Virtus Biotech ETF stock for Q2 2015, up 99% quarter-over-quarter.
- 3 funds opened new Virtus Biotech ETF positions in Q2 2015 and 1 closed out, a net change of +2 holders.
- The largest Virtus Biotech ETF buyer in Q2 2015 was Jane Street, an estimated $360K added.
- The largest Virtus Biotech ETF seller in Q2 2015 was Creative Planning, an estimated $6K sold.
Based on aggregated 13F filings for Q2 2015.